CanCertain is a startup based in the United Kingdom, 1 tracked investor.
Based in the United Kingdom, CanCertain is a startup. Brouky records 1 investor associated with the company.
CanCertain uses advanced 3D cell culture technology to identify the most effective personalized cancer treatment plans with a turnaround time of eight working days, aiming to improve treatment efficacy and patient quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.